Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $2.25 Million - $2.45 Million
-36,313 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$59.34 - $66.74 $32,518 - $36,573
548 Added 1.53%
36,313 $2.29 Million
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $8,834 - $10,010
153 Added 0.43%
35,765 $2.22 Million
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $933,639 - $1.03 Million
-16,257 Reduced 31.34%
35,612 $2.15 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $405,942 - $474,586
-7,405 Reduced 12.49%
51,869 $3.05 Million
Q1 2020

Apr 28, 2020

BUY
$46.4 - $67.43 $1.5 Million - $2.18 Million
32,342 Added 120.09%
59,274 $3.3 Million
Q4 2019

Jan 28, 2020

SELL
$49.21 - $64.19 $21,307 - $27,794
-433 Reduced 1.58%
26,932 $1.73 Million
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $12,788 - $15,162
299 Added 1.1%
27,365 $1.39 Million
Q2 2019

Jul 26, 2019

BUY
$44.62 - $49.34 $144,122 - $159,368
3,230 Added 13.55%
27,066 $1.23 Million
Q1 2019

Apr 22, 2019

BUY
$45.12 - $53.8 $171,365 - $204,332
3,798 Added 18.95%
23,836 $1.21 Million
Q4 2018

Jan 16, 2019

SELL
$48.76 - $63.23 $98,056 - $127,155
-2,011 Reduced 9.12%
20,038 $1.04 Million
Q3 2018

Oct 26, 2018

SELL
$55.19 - $62.25 $41,723 - $47,061
-756 Reduced 3.32%
22,049 $1.37 Million
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $216,116 - $269,365
4,277 Added 23.08%
22,805 $1.26 Million
Q2 2018

Jul 25, 2018

SELL
$50.53 - $62.98 $279,481 - $348,342
-5,531 Reduced 22.99%
18,528 $1.01 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $5,752 - $6,622
96 Added 0.4%
24,059 $1.52 Million
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $32,427 - $35,354
-541 Reduced 2.21%
23,963 $1.47 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $304,206 - $351,079
5,508 Added 29.0%
24,504 $1.56 Million
Q2 2017

Aug 09, 2017

BUY
N/A
18,996
18,996 $1.06 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hedeker Wealth, LLC Portfolio

Follow Hedeker Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hedeker Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hedeker Wealth, LLC with notifications on news.